Contact
searchSearch
HMP Global

Rheumatology & Arthritis

Featured

FDA Approval
FDA Approves Tildrakizumab for Adults With Active Psoriatic Arthritis
11/02/2026
Rebecca Mashaw
The US Food and Drug Administration expanded its approval of tildrakizumab-asmn, an interleukin-23 inhibitor administered by healthcare providers, to include adults with active psoriatic arthritis.
The US Food and Drug Administration expanded its approval of tildrakizumab-asmn, an interleukin-23 inhibitor administered by healthcare providers, to include adults with active psoriatic arthritis.
The US Food and Drug...
11/02/2026
Rheumatology & Arthritis
Research Summary
Gout Linked to Erectile Dysfunction and Lower Reproductive Hormones
10/08/2026
Rebecca Mashaw
The strongest reported sexual health finding in a systematic review and meta-analysis was a higher risk of erectile dysfunction among men with gout.
The strongest reported sexual health finding in a systematic review and meta-analysis was a higher risk of erectile dysfunction among men with gout.
The strongest reported sexual...
10/08/2026
Rheumatology & Arthritis
Research Highlights
Reaching Serum Urate Target Linked to Fewer Cardiovascular Events in Gout
10/08/2026
Rebecca Mashaw
Researchers linked achievement of a serum urate level below 6 mg/dL with fewer major adverse cardiovascular events over 5 years in patients newly prescribed urate-lowering treatment for gout.
Researchers linked achievement of a serum urate level below 6 mg/dL with fewer major adverse cardiovascular events over 5 years in patients newly prescribed urate-lowering treatment for gout.
Researchers linked achievement...
10/08/2026
Rheumatology & Arthritis
Research Review
Study Highlights Quality-of-Life and Productivity Burden Among Caregivers of Patients With Uncontrolled Gout
10/08/2026
Jessica Garlewicz
More than 30% of respondents reported feeling at least "quite a bit" stressed, overwhelmed, or physically exhausted or drained from caring for patients gout.
More than 30% of respondents reported feeling at least "quite a bit" stressed, overwhelmed, or physically exhausted or drained from caring for patients gout.
More than 30% of respondents...
10/08/2026
Rheumatology & Arthritis
Research Highlights
Higher BMI Associated With Reduced Likelihood of Minimal Disease Activity in Psoriatic Arthritis
09/10/2026
Jessica Garlewicz
Subgroup analyses demonstrated that BMI had the greatest impact among patients receiving TNFi therapy with the exception of infliximab.
Subgroup analyses demonstrated that BMI had the greatest impact among patients receiving TNFi therapy with the exception of infliximab.
Subgroup analyses demonstrated...
09/10/2026
Rheumatology & Arthritis
Clinical Trial Overview
Whole-Body MRI Reveals Widespread Inflammation in Early Psoriatic Arthritis
09/10/2026
Rebecca Mashaw
Axial abnormalities were seen in one third of patients at baseline, investigators reported following an analysis of a randomized clinical trial.
Axial abnormalities were seen in one third of patients at baseline, investigators reported following an analysis of a randomized clinical trial.
Axial abnormalities were seen in...
09/10/2026
Rheumatology & Arthritis
FDA Approval
FDA Approves Oral Drug for Dermatomyositis in Adults
08/27/2026
Rebecca Mashaw
Brepocitinib is the first FDA-approved oral treatment option for adult patients with dermatomyositis.
Brepocitinib is the first FDA-approved oral treatment option for adult patients with dermatomyositis.
Brepocitinib is the first...
08/27/2026
Rheumatology & Arthritis
Robert Terkeltaub
Expert Insights
Robert Terkeltaub, MD, on Fiber, Antibiotics, and the Gut Microbiome in Gout
08/24/2026
Robert Terkeltaub, MD
Dr Terkeltaub continues his observations on the role of the gut microbiome in gout, including the critical importance of fiber and how clindamycin is implicated in gout flares.
Dr Terkeltaub continues his observations on the role of the gut microbiome in gout, including the critical importance of fiber and how clindamycin is implicated in gout flares.
Dr Terkeltaub continues his...
08/24/2026
Rheumatology & Arthritis
Research Insights
Real-World Italian Study Supports IL-17 Inhibitor Cycling in Psoriatic Arthritis
07/23/2026
Jessica Garlewicz
Key Clinical Summary A multicenter Italian real-world study of 868 patients with psoriatic arthritis found durable long-term retention of interleukin-17 (IL-17) inhibitors, with overall retention of 77.5% at 12 months and 52.1% at 36...
Key Clinical Summary A multicenter Italian real-world study of 868 patients with psoriatic arthritis found durable long-term retention of interleukin-17 (IL-17) inhibitors, with overall retention of 77.5% at 12 months and 52.1% at 36...
Key Clinical Summary A...
07/23/2026
Rheumatology & Arthritis
Research Summary
Radiographic Damage Repair Seen in One-Third of Patients With Psoriatic Arthritis
07/23/2026
Jessica Garlewicz
  Key Clinical Summary A longitudinal cohort study published in Rheumatology found radiographic damage repair in 29.7% of patients with psoriatic arthritis (PsA) who developed structural joint damage during 7,189.5...
  Key Clinical Summary A longitudinal cohort study published in Rheumatology found radiographic damage repair in 29.7% of patients with psoriatic arthritis (PsA) who developed structural joint damage during 7,189.5...
  Key Clinical...
07/23/2026
Rheumatology & Arthritis
Research Review
Meta-Analysis Finds Comparable Outcomes With TNF Inhibitor Cycling or Mechanism Switching in Psoriatic Arthritis
07/23/2026
Jessica Garlewicz
The meta-analysis found no evidence that either TNFi cycling or switching to a biologic with a different mechanism offers superior effectiveness or safety after initial TNFi failure in psoriatic arthritis.
The meta-analysis found no evidence that either TNFi cycling or switching to a biologic with a different mechanism offers superior effectiveness or safety after initial TNFi failure in psoriatic arthritis.
The meta-analysis found no...
07/23/2026
Rheumatology & Arthritis

Expert Insights

Robert Terkeltaub
Expert Insights
Robert Terkeltaub, MD, on Fiber, Antibiotics, and the Gut Microbiome in Gout
08/24/2026
Robert Terkeltaub, MD
Dr Terkeltaub continues his observations on the role of the gut microbiome in gout, including the critical importance of fiber and how clindamycin is implicated in gout flares.
Dr Terkeltaub continues his observations on the role of the gut microbiome in gout, including the critical importance of fiber and how clindamycin is implicated in gout flares.
Dr Terkeltaub continues his...
08/24/2026
Rheumatology & Arthritis
Philip Mease
Expert Insights
Philip Mease, MD, on the POETYK Trials of Deucravacitinib in PsA
05/11/2026
Philip Mease, MD
In part 1 of a two-part podcast, Dr Mease reviews the findings of two clinical trials of the TYK 2 inhibitor deucravacitinib: POETYK 1 of patients without previous biologic treatment, POETYK 2, which included some patients with exposure to...
In part 1 of a two-part podcast, Dr Mease reviews the findings of two clinical trials of the TYK 2 inhibitor deucravacitinib: POETYK 1 of patients without previous biologic treatment, POETYK 2, which included some patients with exposure to...
In part 1 of a two-part podcast,...
05/11/2026
Rheumatology & Arthritis
Shikha Singla
Expert Insights
Shikha Singla, MD, on Comparative Analysis of Guidelines for PsA
05/11/2026
Shikha Singla, MD
Dr Singla reviews the comparative analysis she and colleagues conducted of guidelines for the diagnosis and treatment of psoriatic arthritis and how they differ between the professional societies.
Dr Singla reviews the comparative analysis she and colleagues conducted of guidelines for the diagnosis and treatment of psoriatic arthritis and how they differ between the professional societies.
Dr Singla reviews the...
05/11/2026
Rheumatology & Arthritis
Shikha Singla
Expert Insights
Shikha Singla, MD, on Comparative Analysis of Guidelines for PsA
05/10/2026
Shikha Singla, MD
Dr Singla reviews the comparative analysis she and colleagues conducted of guidelines for the diagnosis and treatment of psoriatic arthritis and how they differ between the professional societies.
Dr Singla reviews the comparative analysis she and colleagues conducted of guidelines for the diagnosis and treatment of psoriatic arthritis and how they differ between the professional societies.
Dr Singla reviews the...
05/10/2026
Rheumatology & Arthritis
Philip Mease
Expert Insights
Philip Mease, MD, on the POETYK Trials of Deucravacitinib in PsA: Part 2
05/01/2026
Philip Mease, MD
Dr Mease continues his review of the findings of the POETYK clinical trials of the TYK 2 inhibitor deucravacitinib, including patient-reported outcomes among patients treated with the therapy.
Dr Mease continues his review of the findings of the POETYK clinical trials of the TYK 2 inhibitor deucravacitinib, including patient-reported outcomes among patients treated with the therapy.
Dr Mease continues his review of...
05/01/2026
Rheumatology & Arthritis
Philip Mease
Expert Insights
Philip Mease, MD, on the POETYK Trials of Deucravacitinib in PsA: Part 2
04/30/2026
Philip Mease, MD
Dr Mease continues his review of the findings of the POETYK clinical trials of the TYK 2 inhibitor deucravacitinib, including patient-reported outcomes among patients treated with the therapy.
Dr Mease continues his review of the findings of the POETYK clinical trials of the TYK 2 inhibitor deucravacitinib, including patient-reported outcomes among patients treated with the therapy.
Dr Mease continues his review of...
04/30/2026
Rheumatology & Arthritis
Robert Terkeltaub
Expert Insights
Robert Terkeltaub, MD, on the Impact of the Gut Microbiome in Gout
04/23/2026
Robert Terkeltaub, MD
In this video, Dr Robert Terkeltaub reviews how certain mechanisms by which the gut microbiome and genetic variants can affect the disease course of gout.
In this video, Dr Robert Terkeltaub reviews how certain mechanisms by which the gut microbiome and genetic variants can affect the disease course of gout.
In this video, Dr Robert...
04/23/2026
Rheumatology & Arthritis
Philip Mease
Expert Insights
Philip Mease, MD, on the POETYK Trials of Deucravacitinib in PsA
04/23/2026
Philip Mease, MD
In part 1 of a two-part podcast, Dr Mease reviews the findings of two clinical trials of the TYK 2 inhibitor deucravacitinib: POETYK 1 of patients without previous biologic treatment, POETYK 2, which included some patients with exposure to...
In part 1 of a two-part podcast, Dr Mease reviews the findings of two clinical trials of the TYK 2 inhibitor deucravacitinib: POETYK 1 of patients without previous biologic treatment, POETYK 2, which included some patients with exposure to...
In part 1 of a two-part podcast,...
04/23/2026
Rheumatology & Arthritis
Alexis Ogdie
Expert Insights
Alexis Ogdie, MD, on Obesity in Psoriatic Arthritis and GLP-1s: Part 2
04/16/2026
Alexis Ogdie, MD
In part 2 of her video on psoriatic arthritis and obesity, Dr Ogdie reviews recent studies showing how combination therapy with GLP-1 RAs may not only boost weight loss but also help patients achieve minimal disease activity.
In part 2 of her video on psoriatic arthritis and obesity, Dr Ogdie reviews recent studies showing how combination therapy with GLP-1 RAs may not only boost weight loss but also help patients achieve minimal disease activity.
In part 2 of her video on...
04/16/2026
Rheumatology & Arthritis
Alexis Ogdie
Expert Insights
Alexis Ogdie, MD, on the Impact of Obesity in Psoriatic Arthritis: Part 1
04/16/2026
Alexis Ogdie, MD
In the first of two videos on the impact and treatment of obesity in psoriatic arthritis, Dr Alexis Ogdie reviews recent research on how obesity affects the severity of disease and the effect of weight loss on patients with PsA.
In the first of two videos on the impact and treatment of obesity in psoriatic arthritis, Dr Alexis Ogdie reviews recent research on how obesity affects the severity of disease and the effect of weight loss on patients with PsA.
In the first of two videos on...
04/16/2026
Rheumatology & Arthritis

Interactive Features

Quiz
Progression from PsO to PsA
04/28/2026
Rebecca Mashaw
Do you know which patients with psoriasis are most at risk of progression to psoriatic arthritis? Take our quick quiz to find out!
Do you know which patients with psoriasis are most at risk of progression to psoriatic arthritis? Take our quick quiz to find out!
Do you know which patients with...
04/28/2026
Rheumatology & Arthritis
Quiz
Treat-to-Target vs Symptom-Based Gout Care: What’s the Difference?
04/01/2026
Riya Gandhi, MA
Test your understanding of gout management strategies by comparing serum urate treat-to-target approaches with symptom-guided care. This quiz highlights key clinical principles shaping modern gout treatment and long-term disease control.
Test your understanding of gout management strategies by comparing serum urate treat-to-target approaches with symptom-guided care. This quiz highlights key clinical principles shaping modern gout treatment and long-term disease control.
Test your understanding of gout...
04/01/2026
Rheumatology & Arthritis
Quiz
Why Flare Frequency Matters in Clinical Trials
04/01/2026
Riya Gandhi, MA
Explore why gout flare frequency remains a key primary outcome in clinical trials despite the disease’s chronic and erosive nature. This quiz reinforces outcome selection and trial design principles in gout research.
Explore why gout flare frequency remains a key primary outcome in clinical trials despite the disease’s chronic and erosive nature. This quiz reinforces outcome selection and trial design principles in gout research.
Explore why gout flare frequency...
04/01/2026
Rheumatology & Arthritis
Quiz
Hyperuricemia vs Gout: Understanding the Clinical Relationship
04/01/2026
Riya Gandhi, MA
Test your knowledge of the relationship between hyperuricemia and clinical gout. This quiz clarifies key distinctions that impact diagnosis, risk assessment, and treatment decisions in rheumatology practice.
Test your knowledge of the relationship between hyperuricemia and clinical gout. This quiz clarifies key distinctions that impact diagnosis, risk assessment, and treatment decisions in rheumatology practice.
Test your knowledge of the...
04/01/2026
Rheumatology & Arthritis
Quiz
Pegloticase + Methotrexate: What Rising Uric Acid Means
04/01/2026
Riya Gandhi, MA
Assess your understanding of pegloticase therapy by interpreting rising serum urate levels in combination treatment protocols. This quiz highlights key monitoring principles and response criteria from the AGILE trial.
Assess your understanding of pegloticase therapy by interpreting rising serum urate levels in combination treatment protocols. This quiz highlights key monitoring principles and response criteria from the AGILE trial.
Assess your understanding of...
04/01/2026
Rheumatology & Arthritis
Quiz
Sex-Based Differences in Response to Advanced Therapies in Axial Spondyloarthritis
08/07/2025
Rebecca Mashaw
Do men or women achieve better outcomes with advanced therapies for axial spondyloarthritis? Find out by taking our quick quiz.
Do men or women achieve better outcomes with advanced therapies for axial spondyloarthritis? Find out by taking our quick quiz.
Do men or women achieve better...
08/07/2025
Rheumatology & Arthritis
Quiz
What Factor Increases Mortality in Rheumatoid Arthritis?
08/07/2025
Rebecca Mashaw
One factor showed a substantial association with mortality among patients with rheumatoid arthritis. Find out what it is with our quiz!
One factor showed a substantial association with mortality among patients with rheumatoid arthritis. Find out what it is with our quiz!
One factor showed a substantial...
08/07/2025
Rheumatology & Arthritis
Quiz
How to Assess Frailty in SLE
07/21/2025
Rebecca Mashaw
07/21/2025
Rheumatology & Arthritis
Quiz
Continuation of Therapy With bDMARDs vs JAKs in RA
07/21/2025
Rebecca Mashaw
07/21/2025
Rheumatology & Arthritis
Poll
Assessing Bone Loss in Patients With axSpA
12/05/2024
Rebecca Mashaw
Bone loss has been found to play a significant role in axial spondyloarthritis (axSpA) and regular assessments are recommended. How do you assess bone loss in your patients with axSpA?DXA scanTrabecular bone score Quantitative computed...
Bone loss has been found to play a significant role in axial spondyloarthritis (axSpA) and regular assessments are recommended. How do you assess bone loss in your patients with axSpA?DXA scanTrabecular bone score Quantitative computed...
Bone loss has been found to play...
12/05/2024
Rheumatology & Arthritis

About Us

Rheumatology and Arthritis Learning Network® is an online resource for the latest developments in rheumatology practice, providing a customized experience for readers to stay informed about the topics that matter most to them.

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use